Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02445248
Title Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients (JULIET)
Acronym JULIET
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NOR | NLD | ITA | FRA | DEU | CAN | AUT | AUS


No variant requirements are available.